Klacid Paediatric Suspension

Clarithromycin, the active ingredient in Klacid Paediatric Suspension, is a macrolide antibiotic presented as an oral suspension for oral use. It treats bacterial infections such as community‑acquired pneumonia, acute otitis media, sinusitis, and skin infections in children, offering a palatable liquid formulation that can be measured accurately for pediatric dosing.

GNH USA supplies Klacid Paediatric Suspension as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clarithromycin is a macrolide antibiotic used to treat bacterial infections of the respiratory, ear, sinus and skin pathways in pediatric patients.

- Community‑acquired pneumonia: eliminates causative bacteria and improves respiratory function. - Acute otitis media: eradicates ear pathogens and reduces inflammation. - Acute bacterial sinusitis: clears sinus infection and relieves congestion. - Skin and soft‑tissue infections: treats staphylococcal and streptococcal skin infections.

Clarithromycin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Diarrhea: loose stools occurring during therapy. - Nausea: feeling of stomach upset. - Abdominal pain: discomfort in the stomach area. - Taste disturbance: altered taste perception. - Rash: mild skin redness or itching. - Vomiting: expulsion of stomach contents.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Clostridioides difficile‑associated diarrhea: severe colitis risk. - Hepatotoxicity: elevated liver enzymes indicating liver stress. - QT prolongation: potential cardiac rhythm disturbances. - Stevens‑Johnson syndrome: severe skin and mucous membrane reaction. - Severe neutropenia: marked reduction in white blood cells.

When prescribing clarithromycin, clinicians should consider several safety aspects.

- Assess renal function: adjust dosing in severe renal impairment. - Monitor liver enzymes: watch for signs of hepatotoxicity. - Avoid in patients with known macrolide hypersensitivity: risk of allergic reactions. - Evaluate cardiac risk: consider QT interval prolongation in patients with arrhythmias. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Clarithromycin interacts with several medicines; careful review is essential.

Major Interactions (Avoid): - Cisapride: may cause serious cardiac arrhythmias. - Ergot alkaloids: increased risk of ergot toxicity. - Pimozide: heightened risk of QT prolongation.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR and bleeding risk. - Carbamazepine: may reduce clarithromycin plasma levels. - Statins (simvastatin): increased risk of myopathy.